Warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA1 as well as synthesis, activity and application thereof

The invention discloses four kinds of warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA compounds, a preparation method of the compounds, an advantage of the compounds without bleeding side effects, an antagonistic effect of the compounds on a blood coagulation factor II, and an antagonistic effect of the comp...

Full description

Saved in:
Bibliographic Details
Main Authors HOU MENGYU, ZHANG XIAOYI, ZHAO MING, PENG SHIQI
Format Patent
LanguageChinese
English
Published 14.01.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention discloses four kinds of warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA compounds, a preparation method of the compounds, an advantage of the compounds without bleeding side effects, an antagonistic effect of the compounds on a blood coagulation factor II, and an antagonistic effect of the compounds on a tissue factor/blood coagulation factor VII, and discloses the venous thrombosis resisting effect of the compounds. 本发明公开了4种华法林-4-O-乙酰-Gly-Pro-Arg-Pro-AA化合物,公开了它们的制备方法,公开了它们无出血副作用的优点,公开了它们对凝血因子II的拮抗作用,公开了它们对组织因子/凝血因子VII的拮抗作用,公开了它们的抗静脉血栓作用。
AbstractList The invention discloses four kinds of warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA compounds, a preparation method of the compounds, an advantage of the compounds without bleeding side effects, an antagonistic effect of the compounds on a blood coagulation factor II, and an antagonistic effect of the compounds on a tissue factor/blood coagulation factor VII, and discloses the venous thrombosis resisting effect of the compounds. 本发明公开了4种华法林-4-O-乙酰-Gly-Pro-Arg-Pro-AA化合物,公开了它们的制备方法,公开了它们无出血副作用的优点,公开了它们对凝血因子II的拮抗作用,公开了它们对组织因子/凝血因子VII的拮抗作用,公开了它们的抗静脉血栓作用。
Author PENG SHIQI
ZHAO MING
HOU MENGYU
ZHANG XIAOYI
Author_xml – fullname: HOU MENGYU
– fullname: ZHANG XIAOYI
– fullname: ZHAO MING
– fullname: PENG SHIQI
BookMark eNqNzbsKwjAUgOEMOnh7h7h7htiCdCzFy6QOgpvl0J5oIJyEJCh5eyv6AE7f8sM_FSN2TBNxu2LQGAxDCSfAjlK2sLcZzsFBHe5fayUxyhdZ-zFmTg-KJq4kdsk8TcoSuZfovTUdJuNYDkEgp-dirNFGWvycieVue2kOQN61FP0wZEptc1SqqNbVplR18U_zBmsCPKI
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 华法林-4-O-乙酰-Gly-Pro-Arg-Pro-AA1及其合成、活性和应用
ExternalDocumentID CN113929741A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN113929741A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:25:01 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN113929741A3
Notes Application Number: CN202010602719
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220114&DB=EPODOC&CC=CN&NR=113929741A
ParticipantIDs epo_espacenet_CN113929741A
PublicationCentury 2000
PublicationDate 20220114
PublicationDateYYYYMMDD 2022-01-14
PublicationDate_xml – month: 01
  year: 2022
  text: 20220114
  day: 14
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies CAPITAL UNIVERSITY OF MEDICAL SCIENCES
RelatedCompanies_xml – name: CAPITAL UNIVERSITY OF MEDICAL SCIENCES
Score 3.5045538
Snippet The invention discloses four kinds of warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA compounds, a preparation method of the compounds, an advantage of the compounds...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA1 as well as synthesis, activity and application thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220114&DB=EPODOC&locale=&CC=CN&NR=113929741A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFPVNp6LzBxGkTwbtmq3rQ5Et3RzCuiFT96QkbaaT0Y62IvOv91I3txd9SkjgSA7uvu8uuQTgQjjCUgKZm2BKUOZUbCoCKSn6SluaVliTlq5G7vq1zgO7G1aHBXhf1MLk74R-5o8jokUFaO9Z7q-nyySWl9-tTK_kGIfim_bA9Yx5dFzRcMYMr-m2-j2vxw3OXe4b_r1rmpoIIHw21mAdabStraH12NRVKdNVSGnvwEYfpUXZLhS-3kqwxRc_r5Vgszs_8Mbu3PbSPXh-EskII9uIMtrDrapsNqG3kxntJzFtJK8_bcMkIiU6I6fbdBYhwUvH6SXRBQz6nwgiopCsHFsTzQBVPNqH83ZrwDsUF_ryq5UX7i_3ZB1AMYojdQjEDhyFwOcE8rqOoZcU9SCUimG8GVarStaOoPy3nPJ_k8ewrTWs8w8mO4FilnyoU0TkTJ7lqvwGHbSQ-A
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUaP4VROzJxsdKx97WAxsICoMYlB5krRbUQzZyDZj8K_3OkF50ac2bdK0l1x_v7v27gDOuMkNyZG5cSY5ZWaxQrknBMW7siJ0wy8LQ0Ujd9xy64HdDkqDDLwtYmHSPKEfaXJE1CgP9T1J7-vprxPLSf9WxhdijEPhVbNvOdrcOi4qOGOaU7cava7TtTXbtmxXc-8tXVdEAOGztgKrSLGrqtpB47GuolKmy5DS3IS1Hq4WJFuQ-XzNQ85eVF7Lw3pn_uCN3bnuxdvw_MSjEVq2AWW0i0eVyWxCrycz2otCWotevtuaTnhMlEdOtfEsQIIXj-NzogIYVJ0IwgOfLD1bE8UAZTjagdNmo2-3KG50-COVoe3-nsnYhWwQBnIPSMUzJQKf6YnLKppeglc9X0iG9qZfKklR3ofC3-sU_ps8gVyr32kP2zfu3QFsKGkrX4TODiGbRO_yCNE5EcepWL8AEwWT6A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA1+as+well+as+synthesis%2C+activity+and+application+thereof&rft.inventor=HOU+MENGYU&rft.inventor=ZHANG+XIAOYI&rft.inventor=ZHAO+MING&rft.inventor=PENG+SHIQI&rft.date=2022-01-14&rft.externalDBID=A&rft.externalDocID=CN113929741A